Our next major milestone is to finalize the technology PoC and prepare for preclinical testing via an FDA Q-Sub. We are raising a Seed Fund of €600K for the next 12 to 18 months to finalize proof of concept: working prototype in relevant environment, market validation study, FDA Qsub